118683-89-9

Upstream product

• 118683-88-8 1-[2-hydroxy-4-(2-methyl-allyloxy)-phenyl]-ethanone 
• 89-84-9 2',4'-dihydroxy-4-acetophenone 

Downstream Products

• 118683-06-0 4-[4-Acetyl-3-hydroxy-2-(2-methyl-propenyl)-phenoxymethyl]-3-methoxy-benzoic acid 
• 1385690-84-5 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(4-chlorophenyl) prop-2-en-1-one 
• 1385690-85-6 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(4-bromophenyl) prop-2-en-1-one 
• 1385690-86-7 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(4-methoxyphenyl)prop-2-en-1-one 
• 1385690-88-9 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(2,4-dichloro phenyl)prop 2-en-1-one 
• 1385690-91-4 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(1,3-diphenyl-1H-pyrazol-4-yl)prop-2-en-1-one 
• 1385690-93-6 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(1-phenyl-3-p-tolyl-1H-pyrazol-4-yl)prop-2-en-1-one 
• 1385690-72-1 (E)-1-(4-hydroxy-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)-3-(3-(3-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)prop-2-en-1-one 
• 1385690-74-3 1-[4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl]ethanone 
• 1385690-78-7 1-[4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl]ethanone 
• 1385690-82-3 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-phenylprop-2-en-1-one 
• 1385690-83-4 (E)-1-(4-(benzyloxy)-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl)-3-(4-fluorophenyl)prop-2-en-1-one 

Relevant academic research and scientific papers

Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells

A new class of hybrid chalcones (17a-l & 18a-l) was synthesized by Claisen-Schmidt condensation. All compounds were characterized by 1H NMR, IR and mass spectral analysis and tested for their cytotoxic activity against PC-3 (prostate cancer), H

Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes

Considerations of the possible similarities between leukotriene D4 and its prototypical antagonist, FPL 55712, led to the development of a new series of leukotriene antagonists incorporating a hydroxyacetophenone group (e.g., the toluic acids 1